bioAffinity Technologies Presents Research Findings at CYTO 2023

Author's Avatar
May 22, 2023

bioAffinity+Technologies%2C+Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today will present the poster “Development of porphyrin-stained polystyrene compensation beads for use on an automated analysis platform” at CYTO+2023, the annual Congress for the International Society for the Advancement of Cytometry (ISAC), in Montréal, Québec, Canada.ISAC’s mission is to advance the impact of cytometry to meet current and emerging challenges in the life, biomedical and physical sciences.